Cancer Res Treat.  2001 Aug;33(4):286-295.

Expression of Cyclooxygenase-2 in Human Breast Carcinoma: Relevance to Tumor Angiogenesis and Expression of Estrogen Receptor

Affiliations
  • 1Department of Pathology, Hanyang University College of Medicine, Seoul, Korea.
  • 2Department of Surgery, Hanyang University College of Medicine, Seoul, Korea.

Abstract

PURPOSE: This study investigates the COX-2 expression in human primary breast carcinomas and its relationship with both angiogenesis and the expression of estrogen receptor.
MATERIALS AND METHODS
COX-2 expression, angiogenesis, and estrogen receptor expression were examined by immunohistochemical methods in 167 human breast carcinomas by using monoclonal antibodies against COX-2, CD34, and estrogen receptor protein.
RESULTS
Although COX-2 was expressed in 77.8% of the breast carcinomas (130/167) regardless of histological types, it was not detected at all in benign epithelial cells. Interestingly, COX-2 expression was found to be significantly correlated with tumor angiogenesis (p=0.004), but not with estrogen receptor and other histopathologic parameters.
CONCLUSION
The results suggest that COX-2 expression occurs frequently in breast tissue during transformation of benign epithelial cells to malignant cells regardless of the estrogen receptor status. COX-2 expression may play a role in tumor angiogenesis that is responsible for tumor growth and metastasis.

Keyword

Breast neoplasm; Cyclooxygenase-2; Angiogenesis; Estrogen receptor

MeSH Terms

Antibodies, Monoclonal
Breast Neoplasms*
Breast*
Cyclooxygenase 2*
Epithelial Cells
Estrogens*
Humans*
Neoplasm Metastasis
Antibodies, Monoclonal
Cyclooxygenase 2
Estrogens
Full Text Links
  • CRT
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr